Pharmacologic management of overactive bladder - PMC
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685261/
WEBSep 7, 2016 · Currently, there are five such agents approved for the management of OAB in the United States: oxybutynin, tolterodine, trospium, solifenacin and darifenacin. This article summarizes the efficacy, contraindications, precautions, dosing and common side effects of …
DA: 23 PA: 55 MOZ Rank: 77